Tags

Type your tag names separated by a space and hit enter

Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome.
J Infect Dis. 2006 Mar 15; 193(6):792-5.JI

Abstract

In a cohort study of 56 convalescent patients with severe acute respiratory syndrome (SARS), titers of immunoglobulin G (IgG) antibodies and neutralizing antibodies (NAbs) against SARS-associated coronavirus were assessed at regular intervals (at 1, 4, 7, 10, 16, and 24 months after the onset of disease) by use of enzyme-linked immunosorbent assay and neutralization assay. IgG antibody and NAb titers were highly correlated, peaking at month 4 after the onset of disease and decreasing thereafter. IgG antibodies remained detectable in all patients until month 16, and they became undetectable in 11.8% of patients at month 24. The finding that NAbs remained detectable throughout follow-up is reassuring in terms of protection provided against reinfection; however, NAb titers decreased markedly after month 16.

Authors+Show Affiliations

Beijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Beijing, People's Republic of China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16479513

Citation

Liu, Wei, et al. "Two-year Prospective Study of the Humoral Immune Response of Patients With Severe Acute Respiratory Syndrome." The Journal of Infectious Diseases, vol. 193, no. 6, 2006, pp. 792-5.
Liu W, Fontanet A, Zhang PH, et al. Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis. 2006;193(6):792-5.
Liu, W., Fontanet, A., Zhang, P. H., Zhan, L., Xin, Z. T., Baril, L., Tang, F., Lv, H., & Cao, W. C. (2006). Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. The Journal of Infectious Diseases, 193(6), 792-5.
Liu W, et al. Two-year Prospective Study of the Humoral Immune Response of Patients With Severe Acute Respiratory Syndrome. J Infect Dis. 2006 Mar 15;193(6):792-5. PubMed PMID: 16479513.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. AU - Liu,Wei, AU - Fontanet,Arnaud, AU - Zhang,Pan-He, AU - Zhan,Lin, AU - Xin,Zhong-Tao, AU - Baril,Laurence, AU - Tang,Fang, AU - Lv,Hui, AU - Cao,Wu-Chun, Y1 - 2006/02/09/ PY - 2005/07/04/received PY - 2005/09/15/accepted PY - 2006/2/16/pubmed PY - 2006/6/7/medline PY - 2006/2/16/entrez SP - 792 EP - 5 JF - The Journal of infectious diseases JO - J Infect Dis VL - 193 IS - 6 N2 - In a cohort study of 56 convalescent patients with severe acute respiratory syndrome (SARS), titers of immunoglobulin G (IgG) antibodies and neutralizing antibodies (NAbs) against SARS-associated coronavirus were assessed at regular intervals (at 1, 4, 7, 10, 16, and 24 months after the onset of disease) by use of enzyme-linked immunosorbent assay and neutralization assay. IgG antibody and NAb titers were highly correlated, peaking at month 4 after the onset of disease and decreasing thereafter. IgG antibodies remained detectable in all patients until month 16, and they became undetectable in 11.8% of patients at month 24. The finding that NAbs remained detectable throughout follow-up is reassuring in terms of protection provided against reinfection; however, NAb titers decreased markedly after month 16. SN - 0022-1899 UR - https://www.unboundmedicine.com/medline/citation/16479513/Two_year_prospective_study_of_the_humoral_immune_response_of_patients_with_severe_acute_respiratory_syndrome_ DB - PRIME DP - Unbound Medicine ER -